Enrique Caballero, MD
Dr. A. Enrique Caballero is an Endocrinologist, Investigator and Educator. He is the Director of International Innovation Programs in the Office for External Education and the Director of Diabetes Education in the Postgraduate Medical Education Department at Harvard Medical School (HMS) where he leads the development of education programs that benefit health care professionals and patients around the world. He is Associate Professor of Medicine at HMS.
He is also the Director of Latino Diabetes Health in the Division of Endocrinology, Diabetes and Hypertension an Associate Scientist in the Division of Global Health Equity at the Brigham and Hospital (BWH) in Boston, MA. He is the Immediate Past Chair for the Health Care Disparities Committee at the American Diabetes Association (ADA) and Co-chair for the Diabetes Working Group at the National Minority Quality Forum/Center for Sustainable Health Care Quality and Equity.
Dr. Caballero has had a strong and long commitment to help underserved populations. He founded the Latino Diabetes Initiative at the Joslin Diabetes Center and the Diabetes Program within the Spanish Clinic at the BWH, both affiliated with HMS. He has been actively involved with the ADA, the National Hispanic Medical Association, the National Minority Quality Forum (NMQF), the American Association of Clinical Endocrinologists (AACE) and the Latin American Diabetes Association.
His research interests include type 2 diabetes and cardiovascular disease (CVD) prevention as well as management of diabetes in racial/ethnic minorities. He has been a co-investigator of the National Diabetes Prevention Program, the Look AHEAD Program, and the Diabetes Education Study, all sponsored by the NIH.
Dr. Caballero has written numerous publications on how diabetes affects the Latino/Hispanic community, diabetes management and prevention, obesity, and diabetes and CVD. He is also a reviewer for multiple prestigious medical journals and is Associate Editor for Diabetes Research and Clinical Practice, the official journal of the International Diabetes Federation.
Dr. Caballero graduated from the National University of Mexico Medical School where he was awarded with the “Gabino Barreda” medal for being the top student and achieving the highest academic level his class. After completing his training in Internal Medicine, Endocrinology, and Clinical Epidemiology in Mexico, he completed a fellowship program in Endocrinology and Metabolism at the Lahey Clinic/Deaconess Hospital/Joslin Diabetes Center in Boston and the Program on Clinical Effectiveness at the Harvard School of Public Health.
He has received local, regional, national and international recognitions and awards. Dr. Caballero is the recipient of the 2009 “Alberto Houssay” award by the National Minority Quality Forum, the 2011 award by the American Association of Clinical Endocrinologists for his work on health care disparities and with underserved populations and the 2012 Distinguished Community Service and Leadership Award by ALPFA Health Care. Dr. Caballero was recently named an honorary member of the Dominican Republic Endocrinology and Nutrition Society for his contributions to the Hispanic/Latino community. He also received a special recognition from the government of Mexico for his continuous effort and commitment to help underserved populations. He is the recipient of the prestigious 2022 Harvard Medical School Harold Amos award that recognizes exemplary work on Diversity, Inclusion and Equity in Health Care. He is the recipient of the 2023 American Diabetes Association’s Outstanding Educator in Diabetes Award and the 2024 Endocrine Society Outstanding Educator Award.
Dr. Romela Petrosyan is a Board-certified Nephrologist and Proceduralist at the Brigham and Women's Hospital, Department of Medicine, Renal Division and Instructor in Medicine at Harvard Medical School. Quadrilingual (Russian, Armenian, Spanish, and English), former refugee, and third-generation female physician, she is passionate about medical education as well as shaping the culture and execution of health care delivery. With former and current leadership roles of Regent of the American College of Physicians, Delegate to the American Medical Association, Chair of the national Resident and Fellow Council, and Vice Chair of the Early Career Section at the Massachusetts Medical Society, she leads advocacy efforts on behalf of resident and fellow physicians nationally.
Clinically, Dr. Petrosyan subspecializes in the care of patients with chronic kidney disease, diabetic kidney disease, glomerulonephritis, and kidney stones. She is one of two nephrologists at Brigham and Women’s Hospital who performs ultrasound-guided native kidney biopsies.
Dr. Petrosyan is a dedicated resource, supporting the next generation of leaders. Innovation in education and healthcare delivery are the key drivers in her work of developing a point-of-care ultrasonography curriculum and expanding physical examination at Harvard Medical School and nationally. During the 2021 National ACP Internal Medicine Meeting, she presented unique techniques to conducting physical examination over telemedicine. This presentation has been featured by ACP Digital Newspaper, Health Day, Helio, and Oakstone.
She earned her Bachelor of Science (BS) with Summa Cum Laude, Phi Beta Kappa, and Honors in Biological Sciences at University of California, Irvine. She earned her Doctor of Medicine (MD) with a merit-based scholarship at University of Central Florida College of Medicine followed by Internal Medicine residency at University of South Carolina and Nephrology fellowship at the combined Brigham and Women's Hospital and Massachusetts General Hospital Joint Program. She is currently completing a Master of Science in Clinical Service Operations at Harvard Medical School. Dr. Petrosyan has been inducted into fellowship of the American College of Physicians and remains an active national leader within the society.
Jorge Plutzky, MD is Director, Preventive Cardiology at Brigham and Women’s Hospital (BWH) and on the faculty of Harvard Medical School. Dr. Plutzky is a nationally and internationally recognized authority on preventive cardiology, especially known for his unique role regarding cardiometabolic issues and in bridging basic science and clinical issues.
Scientifically, Dr. Plutzky directs a National Institutes of Health (NIH)-funded laboratory studying how metabolic abnormalities promote heart disease in order to identify new therapeutic approaches. In terms of clinical issues, he has been a leader in international clinical trials regarding diabetes and cholesterol, currently chairs the Diabetes Committee of the American Heart Association (AHA), and is involved in studies investigating the increased cardiovascular risk in rheumatologic disorders and HIV.
Clinically, Dr. Plutzky directs the BWH Lipid Clinic and the Pollin Center for Women’s Cardiovascular Health. He is also the Lipid Lead for Mass General Brigham’s Digital Care Transformation program, which uses electronic medical record screening to identify patients who are being undertreated for cardiovascular issues and initiate remote treatment via algorithm-defined care, as this group has applied to hypercholesterolemia, hypertension, heart failure, and now diabetes. Dr. Plutzky’s integrative, interdisciplinary perspectives have led to his role as an advisor to the Food and Drug Administration as well as multiple pharmaceutical and biotechnology entities. Dr. Plutzky is also well known as an educator and mentor, as evidenced by national and international demand for his lectures, his receipt of the BWH Eugene Braunwald Teaching Award, and his mentorship of many trainees now leading their own successful careers in science and medicine.
Dr. Plutzky received his BA with Highest Distinction (Echol’s Scholar) from the University of Virginia and his MD from the University of North Carolina, with Distinction for Research Excellence given his accomplishments during an NIH research fellowship year. Internal medicine residency and cardiology fellowship were completed at Brigham and Women’s Hospital/Harvard Medical School and included a Massachusetts Institute of Technology post-doctoral research fellowship. Recognition for Dr. Plutzky’s contributions include the University of Cologne’s Klenck Award, Harvard Medical School’s Tucker Collins Lectureship, the University of Michigan’s Hurst Visiting Professorship and his election to the American Society of Clinical Investigation.